{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:46:25Z","timestamp":1782819985613,"version":"3.54.5"},"reference-count":50,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2025-0084_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the crosstalk between the serum levels of the metabolic hormones, NO-signaling components, and inflammation markers in patients with coronary artery disease (CAD) with 3-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0084_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 218 included patients underwent coronary angiography and a phone survey with a 3-year follow-up, which included records of cardiovascular (CV) events. Gensini score was evaluated to quantify atherosclerosis. NO-synthases (NOS) were profiled by an Explorer antibody array (Full Moon Biosystems, USA). ELISA was used to assay NOS, endothelin-1, leptin, adiponectin, and cGAMP in the whole cohort. C-reactive protein (CRP), glucose, and insulin were measured according to a routine analysis. Serum NOx were measured spectrophotometrically under diet in a hospital setting. Spearman correlation analysis, ROC-analysis, and logistic regressions were used to evaluate the associations between analytes, Gensini score, and CV-events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0084_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Correlation analysis reveals a complex network in which leptin deficiency appears to be a central, unfavorable and independent factor linked to CV-events. A pathological cycle involved hormone levels, imbalanced NOS isoforms and endothelin, metabolic factors, and CRP as inflammation marker. The direct pro-atherogenic roles of glucose, insulin, and CRP, and the protective potential of adiponectin and NOx were revealed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0084_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Atherosclerosis was linked to a decrease in NOx. Elevated NOS isoforms may compensate for impaired NOS activity in atherosclerosis. Specific changes in the levels of NOS and NOx may be linked to the signaling pathways contributing to atherosclerosis and point to the correction of these changes using exogenous nitrate as dietary supplement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2025-0084","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:08:15Z","timestamp":1779689295000},"page":"69-79","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic hormones, nitric oxide signaling components, and inflammation markers crosstalk in coronary artery disease"],"prefix":"10.1515","volume":"47","author":[{"given":"Nadezhda G.","family":"Gumanova","sequence":"first","affiliation":[{"name":"National Research Center for Preventive Medicine (NRCPM) (New Name \u201cNational Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation\u201d) , Moscow , Russia"},{"name":"Department of Biochemistry , National Research Center for Preventive Medicine (NRCPM) or FSBI National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya L.","family":"Bogdanova","sequence":"additional","affiliation":[{"name":"National Research Center for Preventive Medicine (NRCPM) (New Name \u201cNational Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation\u201d) , Moscow , Russia"},{"name":"Department of Biochemistry , National Research Center for Preventive Medicine (NRCPM) or FSBI National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton R.","family":"Kiselev","sequence":"additional","affiliation":[{"name":"National Research Center for Preventive Medicine (NRCPM) (New Name \u201cNational Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation\u201d) , Moscow , Russia"},{"name":"Department of Fundamental Science , National Research Center for Preventive Medicine (NRCPM) or FSBI National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health\u0441are of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"2026063010571583154_j_hmbci-2025-0084_ref_001","doi-asserted-by":"crossref","unstructured":"Moncada, S, Palmer, RM, Higgs, EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109\u201342. https:\/\/doi.org\/10.1016\/s0031-6997(25)06663-3.","DOI":"10.1016\/S0031-6997(25)06663-3"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_002","doi-asserted-by":"crossref","unstructured":"Yanai, H, Yoshida, H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci 2019;20:1190. https:\/\/doi.org\/10.3390\/ijms20051190.","DOI":"10.3390\/ijms20051190"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_003","doi-asserted-by":"crossref","unstructured":"Gumanova, NG. Nitric oxide and its circulating NOx metabolites, their role in human body functioning and cardiovascular death risk prediction (part I). Russian J Prev Med. 2021;24:102\u20139. (In Russ.). https:\/\/doi.org\/10.17116\/profmed202124091102.","DOI":"10.17116\/profmed202124091102"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_004","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E, Bojdo, K, Frankenstein, H, Krawiranda, K, Kustosik, N, Lisi\u0144ska, W, et al.. Endothelial dysfunction as the common pathway linking obesity, hypertension and atherosclerosis. Int J Mol Sci 2025;26:10096. https:\/\/doi.org\/10.3390\/ijms262010096.","DOI":"10.3390\/ijms262010096"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_005","doi-asserted-by":"crossref","unstructured":"Van de Voorde, J, Pauwels, B, Boydens, C, Decaluw\u00e9, K. Adipocytokines in relation to cardiovascular disease. Metabolism 2013;62:1513\u201321. https:\/\/doi.org\/10.1016\/j.metabol.2013.06.004.","DOI":"10.1016\/j.metabol.2013.06.004"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_006","doi-asserted-by":"crossref","unstructured":"Galluccio, E, Piatti, P, Citterio, L, Lucotti, PC, Setola, E, Cassina, L, et al.. Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis. Am J Physiol Endocrinol Metab 2008;294:E978\u201386. https:\/\/doi.org\/10.1152\/ajpendo.00003.2008.","DOI":"10.1152\/ajpendo.00003.2008"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_007","doi-asserted-by":"crossref","unstructured":"Oemar, BS, Tschudi, MR, Godoy, N, Brovkovich, V, Malinski, T, L\u00fcscher, TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998;97:2494\u20138. https:\/\/doi.org\/10.1161\/01.cir.97.25.2494.","DOI":"10.1161\/01.CIR.97.25.2494"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_008","doi-asserted-by":"crossref","unstructured":"Kanaan, GN, Harper, ME. Cellular redox dysfunction in the development of cardiovascular diseases. Biochim Biophys Acta Gen Subj 2017;1861:2822\u20139. https:\/\/doi.org\/10.1016\/j.bbagen.2017.07.027.","DOI":"10.1016\/j.bbagen.2017.07.027"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_009","doi-asserted-by":"crossref","unstructured":"F\u00f6rstermann, U, Sessa, WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33:829\u201337, 837a-837d. https:\/\/doi.org\/10.1093\/eurheartj\/ehr304.","DOI":"10.1093\/eurheartj\/ehr304"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_010","doi-asserted-by":"crossref","unstructured":"L\u00fcscher, TF, Richard, V, Tschudi, M, Yang, ZH, Boulanger, C. Endothelial control of vascular tone in large and small coronary arteries. J\u00a0Am Coll Cardiol 1990;15:519\u201327. https:\/\/doi.org\/10.1016\/0735-1097(90)90619-z.","DOI":"10.1016\/0735-1097(90)90619-Z"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_011","doi-asserted-by":"crossref","unstructured":"Sharma, HS, Wiklund, L, Badgaiyan, RD, Mohanty, S, Alm, P. Intracerebral administration of neuronal nitric oxide synthase antiserum attenuates traumatic brain injury-induced blood-brain barrier permeability, brain edema formation, and sensory motor disturbances in the rat. Acta Neurochir Suppl 2006;96:288\u201394. https:\/\/doi.org\/10.1007\/3-211-30714-1_62.","DOI":"10.1007\/3-211-30714-1_62"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_012","doi-asserted-by":"crossref","unstructured":"O\u2019Mahony, D, Kendall, MJ. Nitric oxide in acute ischaemic stroke: a target for neuroprotection. J\u00a0Neurol Neurosurg Psychiatry 1999;67:1\u20133. https:\/\/doi.org\/10.1136\/jnnp.67.1.1.","DOI":"10.1136\/jnnp.67.1.1"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_013","doi-asserted-by":"crossref","unstructured":"Gallo, MP, Malan, D, Bedendi, I, Biasin, C, Alloatti, G, Levi, RC. Regulation of cardiac calcium current by NO and cGMP-modulating agents. Pfl\u00fcgers Archiv 2001;441:621\u20138. https:\/\/doi.org\/10.1007\/s004240000475.","DOI":"10.1007\/s004240000475"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_014","doi-asserted-by":"crossref","unstructured":"Ally, A, Powell, I, Ally, MM, Chaitoff, K, Nauli, SM. Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states. Nitric Oxide 2020;102:52\u201373. https:\/\/doi.org\/10.1016\/j.niox.2020.06.004.","DOI":"10.1016\/j.niox.2020.06.004"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_015","doi-asserted-by":"crossref","unstructured":"Marletta, MA. Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated? Trends Biochem Sci 2001;26:519\u201321. https:\/\/doi.org\/10.1016\/s0968-0004(01)01937-5.","DOI":"10.1016\/S0968-0004(01)01937-5"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_016","doi-asserted-by":"crossref","unstructured":"Bredt, DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999;31:577\u201396. https:\/\/doi.org\/10.1080\/10715769900301161.","DOI":"10.1080\/10715769900301161"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_017","doi-asserted-by":"crossref","unstructured":"Tran, N, Garcia, T, Aniqa, M, Ali, S, Ally, A, Nauli, SM. Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states. Am J Biomed Sci Res 2022;15:153\u201377.","DOI":"10.34297\/AJBSR.2022.15.002087"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_018","doi-asserted-by":"crossref","unstructured":"Gebhart, V, Rei\u00df, K, Kollau, A, Mayer, B, Gorren, ACF. Site and mechanism of uncoupling of nitric-oxide synthase: uncoupling by monomerization and other misconceptions. Nitric Oxide 2019;89:14\u201321. https:\/\/doi.org\/10.1016\/j.niox.2019.04.007.","DOI":"10.1016\/j.niox.2019.04.007"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_019","doi-asserted-by":"crossref","unstructured":"Violi, F, Pignatelli, P, Pignata, C, Plebani, A, Rossi, P, Sanguigni, V, et al.. Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress. Arterioscler Thromb Vasc Biol 2013;33:406\u201312. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300438.","DOI":"10.1161\/ATVBAHA.112.300438"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_020","doi-asserted-by":"crossref","unstructured":"Gliozzi, M, Scicchitano, M, Bosco, F, Musolino, V, Carresi, C, Scarano, F, et al.. Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development. Int J Mol Sci 2019;20:3294. https:\/\/doi.org\/10.3390\/ijms20133294.","DOI":"10.3390\/ijms20133294"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_021","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Altay\u00f3, F, Ortiz-Romero, P, Puertas-Umbert, L, Dantas, AP, P\u00e9rez, B, Vila, E, et al.. Stenosis coexists with compromised \u03b11-adrenergic contractions in the ascending aorta of a mouse model of Williams-Beuren syndrome. Sci Rep 2020;10:889. https:\/\/doi.org\/10.1038\/s41598-020-57803-3.","DOI":"10.1038\/s41598-020-57803-3"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_022","doi-asserted-by":"crossref","unstructured":"Cromheeke, KM, Kockx, MM, De Meyer, GR, Bosmans, JM, Bult, H, Beelaerts, WJ, et al.. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation\/peroxidation in human atherosclerotic plaques. Cardiovasc Res 1999;43:744\u201354. https:\/\/doi.org\/10.1016\/s0008-6363(99)00148-0.","DOI":"10.1016\/S0008-6363(99)00148-0"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_023","doi-asserted-by":"crossref","unstructured":"Kuhlencordt, PJ, Chen, J, Han, F, Astern, J, Huang, PL. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001;103:3099\u2013104. https:\/\/doi.org\/10.1161\/01.cir.103.25.3099.","DOI":"10.1161\/01.CIR.103.25.3099"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_024","doi-asserted-by":"crossref","unstructured":"Koglin, J, Glysing-Jensen, T, Mudgett, JS, Russell, ME. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice. Am J Pathol 1998;153:1371\u20136. https:\/\/doi.org\/10.1016\/S0002-9440(10)65723-9.","DOI":"10.1016\/S0002-9440(10)65723-9"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_025","doi-asserted-by":"crossref","unstructured":"Somers, JR, Beck, PL, Lees-Miller, JP, Roach, D, Li, Y, Guo, J, et al.. iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin. Am J Physiol Heart Circ Physiol 2008;295:H1122\u201331. https:\/\/doi.org\/10.1152\/ajpheart.00386.2008.","DOI":"10.1152\/ajpheart.00386.2008"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_026","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Klimushina, MV, Smetnev, SA, Kiseleva, AV, Skirko, OP, Meshkov, AN, et al.. Levels of nitric oxide metabolites, adiponectin and endothelin are associated with SNPs of the adiponectin and endothelin genes. Biomed Rep 2019;11:154\u201364. https:\/\/doi.org\/10.3892\/br.2019.1238.","DOI":"10.3892\/br.2019.1238"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_027","doi-asserted-by":"crossref","unstructured":"Koleva-Tyutyundzhieva, D, Ilieva-Gerova, M, Deneva, T, Orbetzova, M. Metabolic and inflammatory adipokine profiles in PCOS: a focus on adiposity, insulin resistance, and atherogenic risk. Int J Mol Sci 2025;26:9702. https:\/\/doi.org\/10.3390\/ijms26199702.","DOI":"10.3390\/ijms26199702"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_028","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Vasilyev, DK, Bogdanova, NL, Havrichenko, YI, Kots, AY, Metelskaya, VA. Application of an antibody microarray for serum protein profiling of coronary artery stenosis. Biochem Biophys Res Commun 2022;631:55\u201363. https:\/\/doi.org\/10.1016\/j.bbrc.2022.09.053.","DOI":"10.1016\/j.bbrc.2022.09.053"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_029","doi-asserted-by":"crossref","unstructured":"Task Force, M; Montalescot, G, Sechtem, U, Achenbach, S, Andreotti, F, Arden, C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003. https:\/\/doi.org\/10.1093\/eurheartj\/eht296.","DOI":"10.1093\/eurheartj\/eht296"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_030","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Vasilyev, DK, Bogdanova, NL, Havrichenko, YI, Drapkina, OM. P-E-and H-cadherins differ in their relationships with coronary stenosis, cardiovascular events, and unplanned recurrent revascularization. J\u00a0Mol Cell Cardiol 2024;9:100091. https:\/\/doi.org\/10.1016\/j.jmccpl.2024.100091.","DOI":"10.1016\/j.jmccpl.2024.100091"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_031","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Bogdanova, NL, Metelskaya, VA. Proteomic biomarker evaluation using antibody microarrays: association between analytical methods such as microarray and ELISA. Lab Med 2024;55:325\u201333. https:\/\/doi.org\/10.1093\/labmed\/lmad083.","DOI":"10.1093\/labmed\/lmad083"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_032","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Bogdanova, NL, Gorshkov, AY. Associations of serum levels of cGAMP in the context of COVID-19 infection, atherosclerosis, sterile inflammation, and functional endothelial biomarkers in patients with coronary heart disease and healthy volunteers. Horm Mol Biol Clin Invest 2025;46:93\u2013101. https:\/\/doi.org\/10.1515\/hmbci-2024-0073.","DOI":"10.1515\/hmbci-2024-0073"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_033","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Gavrilova, NE, Chernushevich, OI, Kots, AY, Metelskaya, VA. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers 2017;22:239\u201345. https:\/\/doi.org\/10.1080\/1354750X.2016.1201539.","DOI":"10.1080\/1354750X.2016.1201539"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_034","doi-asserted-by":"crossref","unstructured":"Miranda, KM, Espey, MG, Wink, DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62\u201371. https:\/\/doi.org\/10.1006\/niox.2000.0319.","DOI":"10.1006\/niox.2000.0319"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_035","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Klimushina, MV, Metel\u2019skaya, VA. Optimization of single-step assay for circulating nitrite and nitrate ions (NOx) as risk factors of cardiovascular mortality. Bull Exp Biol Med 2018;165:284\u20137. https:\/\/doi.org\/10.1007\/s10517-018-4149-z.","DOI":"10.1007\/s10517-018-4149-z"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_036","doi-asserted-by":"crossref","unstructured":"Gensini, GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. https:\/\/doi.org\/10.1016\/s0002-9149(83)80105-2.","DOI":"10.1016\/S0002-9149(83)80105-2"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_037","doi-asserted-by":"crossref","unstructured":"Kim, ME, Lee, JS. Advances in the regulation of inflammatory mediators in nitric oxide synthase: implications for disease modulation and therapeutic approaches. Int J Mol Sci 2025;26:1204. https:\/\/doi.org\/10.3390\/ijms26031204.","DOI":"10.3390\/ijms26031204"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_038","doi-asserted-by":"crossref","unstructured":"F\u00f6rstermann, U. cGAMP-Dependent PKG1 activation in perspective. Circulation 2023;148:1035\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066073.","DOI":"10.1161\/CIRCULATIONAHA.123.066073"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_039","doi-asserted-by":"crossref","unstructured":"Yu, SM, Hung, LM, Lin, CC. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 1997;95:1269\u201377. https:\/\/doi.org\/10.1161\/01.cir.95.5.1269.","DOI":"10.1161\/01.CIR.95.5.1269"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_040","doi-asserted-by":"crossref","unstructured":"Strasen, J, Ritter, O. Role of nNOS in cardiac ischemia-reperfusion injury. Trends Cardiovasc Med 2011;21:58\u201363. https:\/\/doi.org\/10.1016\/j.tcm.2012.03.001.","DOI":"10.1016\/j.tcm.2012.03.001"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_041","doi-asserted-by":"crossref","unstructured":"Hu, L, Wang, J, Zhu, H, Wu, X, Zhou, L, Song, Y, et al.. Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria. Cell Death Dis 2016;7:e2222. https:\/\/doi.org\/10.1038\/cddis.2016.108.","DOI":"10.1038\/cddis.2016.108"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_042","doi-asserted-by":"crossref","unstructured":"Guber, S, Ebrahimian, T, Heidari, M, Eliopoulos, N, Lehoux, S. Endothelial nitric oxide synthase overexpressing human early outgrowth cells inhibit coronary artery smooth muscle cell migration through paracrine functions. Sci Rep 2018;8:877. https:\/\/doi.org\/10.1038\/s41598-017-18848-z.","DOI":"10.1038\/s41598-017-18848-z"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_043","doi-asserted-by":"crossref","unstructured":"Zhang, W, Xu, XL, Wang, YQ, Wang, CH, Zhu, WZ. Effects of 2,3,4\u2019,5-tetrahydroxystilbene 2-O-beta-D-glucoside on vascular endothelial dysfunction in atherogenic-diet rats. Planta Med 2009;75:1209\u201314. https:\/\/doi.org\/10.1055\/s-0029-1185540.","DOI":"10.1055\/s-0029-1185540"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_044","doi-asserted-by":"crossref","unstructured":"Gumanova, NG, Teplova, NV, Ryabchenko, AU, Denisov, EN. Serum nitrate and nitrite levels in patients with hypertension and ischemic stroke depend on diet: a multicenter study. Clin Biochem 2015;48:29\u201332. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.10.010.","DOI":"10.1016\/j.clinbiochem.2014.10.010"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_045","doi-asserted-by":"crossref","unstructured":"Liu, Y, Croft, KD, Mori, TA, Gaspari, TA, Kemp-Harper, BK, Ward, NC. Long-term dietary nitrate supplementation slows the progression of established atherosclerosis in ApoE-\/- mice fed a high fat diet. Eur J Nutr 2023;62:1845\u201357. https:\/\/doi.org\/10.1007\/s00394-023-03127-7.","DOI":"10.1007\/s00394-023-03127-7"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_046","doi-asserted-by":"crossref","unstructured":"Ellis, G, Adatia, I, Yazdanpanah, M, Makela, SK. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin Biochem 1998;31:195\u2013220. https:\/\/doi.org\/10.1016\/s0009-9120(98)00015-0.","DOI":"10.1016\/S0009-9120(98)00015-0"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_047","doi-asserted-by":"crossref","unstructured":"Samatova, KS, Gumanova, NG, Korolev, AI, Bogdanova, NL, Gorshkov, AY, Kiselev, AR, et al.. The effect of an exogenous source of nitrate ions\u00a0\u2013\u00a0beetroot powder\u00a0\u2013\u00a0on blood pressure and arterial stiffness in a pilot preclinical study. Rational Pharmacother Cardiol 2025;21:435\u201340. https:\/\/doi.org\/10.20996\/1819-6446-2025-3270.EDN:HIUNIP.","DOI":"10.20996\/1819-6446-2025-3270"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_048","doi-asserted-by":"crossref","unstructured":"Samatova, KS, Gumanova, NG, Korolev, AI, Ososkov, VS, Bogdanova, NL, Gorshkov, AY, et al.. The effect of beetroot powder (BETA-NO\u25cf-BOOST), a natural source of nitrate and nitrite ions, on serum lipids and cardiovascular and inflammatory markers: a pilot study. Russ Open Med J 2025;14:e0416. https:\/\/doi.org\/10.15275\/rusomj.2025.0416.","DOI":"10.15275\/rusomj.2025.0416"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_049","doi-asserted-by":"crossref","unstructured":"Ku, IA, Farzaneh-Far, R, Vittinghoff, E, Zhang, MH, Na, B, Whooley, MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the heart and soul study. Atherosclerosis 2011;217:503\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.10.047.","DOI":"10.1016\/j.atherosclerosis.2010.10.047"},{"key":"2026063010571583154_j_hmbci-2025-0084_ref_050","doi-asserted-by":"crossref","unstructured":"Perakakis, N, Farr, OM, Mantzoros, CS. Leptin in leanness and obesity: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 2021;77:745\u201360. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.069.","DOI":"10.1016\/j.jacc.2020.11.069"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0084\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:03:01Z","timestamp":1782817381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0084\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,26]]},"published-print":{"date-parts":[[2026,6,24]]}},"alternative-id":["10.1515\/hmbci-2025-0084"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2025-0084","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}